These effects enable sustained weight management in clinical settings, with healthcare providers finding that patients experience enhanced metabolic control, reduced cravings, and ultimately improved long-term outcomes in obesity treatment programs
Both medications may be considered for individuals with obesity or who are overweight with at least one weight-related condition, such as high blood pressure, high cholesterol, or Type 2 diabetes
Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome
Going to bed with very low blood sugar can trigger cortisol release that fragments sleep
Similarly, gallbladder issues like gallstones can arise
When you raise your hand, your team can collaborate with you to identify the optimal plan and set expectations, such as understanding that a plateau is typical around weeks 40 to 48